Skip to content
healthcare.dev

AMELUZ

NDC 70621-101, aminolevulinic acid hydrochloride, gel, from Biofrontera Inc..

Product NDC
70621-101
Status
Listed
Labeler
Biofrontera Inc.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA208081
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70621-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMINOLEVULINIC ACID HYDROCHLORIDE100 mg/g

Pharmacologic classes

Fluorescence Contrast Activity [MoA]; Optical Imaging Agent [EPC]; Porphyrin Precursor [EPC]; Porphyrinogens [CS]

Package NDCNDC-11Package
70621-101-10706210101101 TUBE in 1 PACKAGE (70621-101-10) / 2 g in 1 TUBE (70621-101-01)
70621-101-207062101012010 TUBE in 1 PACKAGE (70621-101-20) / 2 g in 1 TUBE (70621-101-01)
70621-101-30706210101301 TUBE in 1 PACKAGE (70621-101-30) / 2 g in 1 TUBE (70621-101-03)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/650daa9f-aeec-49ce-95b9-5fa20b988afd
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70621-101

Use it

Look up 70621-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70621-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70621-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.